BioCardia, Inc.
BCDA· Nasdaq
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001437749-25-034437
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $357.00K | $212.00K |
| Net Income | -$1.48M | -$1.74M | -$2.57M | -$3.06M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end